NO983437D0 - Administreringsformer med umiddelbar frigivelse, samt fremgangsmÕte for fremstilling av slike - Google Patents

Administreringsformer med umiddelbar frigivelse, samt fremgangsmÕte for fremstilling av slike

Info

Publication number
NO983437D0
NO983437D0 NO983437A NO983437A NO983437D0 NO 983437 D0 NO983437 D0 NO 983437D0 NO 983437 A NO983437 A NO 983437A NO 983437 A NO983437 A NO 983437A NO 983437 D0 NO983437 D0 NO 983437D0
Authority
NO
Norway
Prior art keywords
administration
well
release forms
making
methods
Prior art date
Application number
NO983437A
Other languages
English (en)
Other versions
NO983437L (no
NO323625B1 (no
Inventor
Rolf-Dieter Gabel
Alexander Wirl
Heinrich Woog
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO983437D0 publication Critical patent/NO983437D0/no
Publication of NO983437L publication Critical patent/NO983437L/no
Publication of NO323625B1 publication Critical patent/NO323625B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO19983437A 1996-01-26 1998-07-24 Faste administreringsformer med umiddelbar frigivelse, samt fremgangsmate for fremstilling av slike NO323625B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602757A DE19602757A1 (de) 1996-01-26 1996-01-26 Feste Instant-Release-Darreichungsformen und Verfahren zu ihrer Herstellung
PCT/EP1997/000329 WO1997026867A2 (de) 1996-01-26 1997-01-24 Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
NO983437D0 true NO983437D0 (no) 1998-07-24
NO983437L NO983437L (no) 1998-09-28
NO323625B1 NO323625B1 (no) 2007-06-18

Family

ID=7783738

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19983437A NO323625B1 (no) 1996-01-26 1998-07-24 Faste administreringsformer med umiddelbar frigivelse, samt fremgangsmate for fremstilling av slike

Country Status (21)

Country Link
US (1) US6521262B2 (no)
EP (1) EP0877605B1 (no)
JP (1) JP2000506512A (no)
KR (1) KR19990082039A (no)
CN (1) CN1214629A (no)
AT (1) ATE226065T1 (no)
AU (1) AU717456B2 (no)
BR (1) BR9707083A (no)
CA (1) CA2243964A1 (no)
CZ (1) CZ298897B6 (no)
DE (2) DE19602757A1 (no)
ES (1) ES2184987T3 (no)
HU (1) HU224953B1 (no)
IL (1) IL125474A (no)
MX (1) MX9805939A (no)
NO (1) NO323625B1 (no)
NZ (1) NZ331051A (no)
PL (1) PL328157A1 (no)
RU (1) RU2175547C2 (no)
WO (1) WO1997026867A2 (no)
ZA (1) ZA97596B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2241342C (en) * 1998-06-15 2000-02-08 Bernard Charles Sherman Pharmaceutical tablets comprising an nsaid and a prostaglandin
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ES2243840T3 (es) * 2003-07-25 2005-12-01 Ferring B.V. Composicion farmaceutica de desmopresina como forma farmaceutica solida de dosificacion y metodo para la fabricacion de la misma.
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
CA2594229A1 (en) 2004-12-30 2006-07-06 Medivir Ab 2',3'-dideoxy-3'-c-hyroxymethylcytidine and prodrugs thereof for the treatment of drug escape mutant hiv
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4283394A (en) * 1979-08-06 1981-08-11 Research Corporation Cytotoxic nucleoside-corticosteroid phosphodiesters
US4622392A (en) * 1984-06-21 1986-11-11 Health Research Inc. (Roswell Park Division) Thiophospholipid conjugates of antitumor agents
US4605551A (en) * 1984-11-30 1986-08-12 William H. Rorer, Inc. Dry oil coated antacid process
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
SE9003902D0 (sv) 1990-12-07 1990-12-07 Astra Ab Solid dosage forms of a drug
DE4026265A1 (de) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel

Also Published As

Publication number Publication date
NO983437L (no) 1998-09-28
IL125474A0 (en) 1999-03-12
PL328157A1 (en) 1999-01-18
RU2175547C2 (ru) 2001-11-10
WO1997026867A3 (de) 1997-09-25
ES2184987T3 (es) 2003-04-16
HU224953B1 (en) 2006-04-28
JP2000506512A (ja) 2000-05-30
US20020122817A1 (en) 2002-09-05
KR19990082039A (ko) 1999-11-15
CA2243964A1 (en) 1997-07-31
AU1594897A (en) 1997-08-20
CZ232098A3 (cs) 1998-10-14
ATE226065T1 (de) 2002-11-15
NZ331051A (en) 2000-01-28
CZ298897B6 (cs) 2008-03-05
MX9805939A (es) 1998-11-30
US6521262B2 (en) 2003-02-18
DE59708495D1 (de) 2002-11-21
WO1997026867A2 (de) 1997-07-31
NO323625B1 (no) 2007-06-18
HUP9902415A2 (hu) 1999-11-29
EP0877605B1 (de) 2002-10-16
CN1214629A (zh) 1999-04-21
HUP9902415A3 (en) 1999-12-28
DE19602757A1 (de) 1997-07-31
AU717456B2 (en) 2000-03-23
BR9707083A (pt) 1999-03-23
EP0877605A2 (de) 1998-11-18
IL125474A (en) 2001-12-23
ZA97596B (en) 1998-07-24

Similar Documents

Publication Publication Date Title
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
PT971717E (pt) Amino-acucar citotoxico e derivados de acucar afins de indolopirrolocarbazois
FI964681A0 (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
ATE231872T1 (de) Thiazolopyrimidinderivate
DE69905368T2 (de) Oxydiertes thymosin beta 4
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
PL1765337T3 (pl) Połączenie tenofowiru, ritonawiru i TMC114
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
NO983437D0 (no) Administreringsformer med umiddelbar frigivelse, samt fremgangsmÕte for fremstilling av slike
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
DE69700983D1 (de) Ligandgerichtete enzyme-prodrug therapie
AP2001002369A0 (en) Pharmaceutical complex.
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
SE9803107D0 (sv) Novel Compunds
ATE211383T1 (de) Topische aciclovir-zubereitung
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
SE9803277D0 (sv) Novel compounds
FR2846328B1 (fr) Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.